International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2026 Annual Meeting

Lymphoma Coalition has been accepted to present new research at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2026 Annual Meeting, taking place in Philadelphia, USA, in May 2026.

Marjorie Morrison, Director, Policy & Advocacy at Lymphoma Coalition, represents the organisation on the ISPOR 2026 International Program Committee and will present the poster. The study, Patient-Reported Experiences with Cancer-Related Fatigue Following CAR T-Cell Therapy, explores the impact of cancer-related fatigue (CRF) in individuals with lymphoma and chronic lymphocytic leukaemia (CLL).

Drawing on data from the 2024 Global Patient Survey, the findings highlight CRF as the most frequently reported adverse event following CAR-T therapy, with a substantial impact on patients’ quality of life. Despite its prevalence and severity, the research also identifies gaps in communication and support, with many patients reporting limited discussion of CRF with their healthcare providers. These findings reinforce the importance of recognising and addressing CRF within clinical practice, supporting more comprehensive, patient-centred care and improved quality of life outcomes.